Advertisement

Topics

Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on ...

16:01 EST 8 Nov 2017 | BioMedReports - Blog

"Our team has been busy with preparations to launch the HOPE-2 clinical trial of CAP-1002, for which we recently submitted an Investigational New Drug application

Read more...

Original Article: Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on ...

NEXT ARTICLE

More From BioPortfolio on "Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...